Edurant Contraindications

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Contraindications

EDURANT (rilpivirine) is contraindicated in patients who are hypersensitive to rilpivirine or to any ingredient in the formulation. For a complete listing of ingredients, see Description.
Co-administration of EDURANT is contraindicated with drugs which induce CYP3A enzymes or increase gastric pH as this may result in significant decreases in the plasma concentrations of rilpivirine, a loss of virologic response and possible resistance to EDURANT and to the NNRTI class of antiretrovirals. These drugs are listed in Table 7 (see Drug-Drug Interactions: Table 11 under Interactions). (See Table 7.)

Click on icon to see table/diagram/image

rilpivirine

Manufacturer:

Johnson & Johnson

Distributor:

DCH Auriga - Healthcare